Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics

Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics

ISBN-10:
3319876678
ISBN-13:
9783319876672
Pub. Date:
09/05/2018
Publisher:
Springer International Publishing
ISBN-10:
3319876678
ISBN-13:
9783319876672
Pub. Date:
09/05/2018
Publisher:
Springer International Publishing
Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics

Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics

$219.99
Current price is , Original price is $219.99. You
$219.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Overview

This book presents descriptive overviews of gene editing strategies across multiple species while also offering in-depth insight on complex cases of application in the field of tissue engineering and regenerative medicine. Chapters feature contributions from leaders in stem cell therapy and biology, providing a comprehensive view of the application of gene therapy in numerous fields with an emphasis on ophthalmology, stem cells, and agriculture. The book also highlights recent major technological advances, including ZFN, TALEN, and CRISPR. Precision Medicine, CRISPR, and Genome Engineering is part of the highly successful Advances in Experimental Medicine and Biology series. It is an indispensable resource for researchers and students in genetics as well as clinicians.

Product Details

ISBN-13: 9783319876672
Publisher: Springer International Publishing
Publication date: 09/05/2018
Series: Advances in Experimental Medicine and Biology , #1016
Edition description: Softcover reprint of the original 1st ed. 2017
Pages: 178
Product dimensions: 6.10(w) x 9.25(h) x (d)

About the Author

For years, Stephen Tsang has been culturing embryonic stem (ES) cells and created the first mouse model for a recessive form of retinitis pigmentosa by applying homologous recombination to ES cell technology. Two elements define his laboratory. First, by leveraging his genetics clinical practice, in which over 1000 retinal patients are cared for, he brings an array of clinical resources to his research, including stem cells and live imaging data. Second, he and his students are recognized authorities in a broad array of state-of-the-art technologies. Most recently, he was invited as a Moderator for the Gene Editing/Rewriting the Genome session during the 65th American Society of Human Genetics Annual Meeting.

Table of Contents

Part 1. Introduction to the CRISPR Revolution.- 1. Viral Vectors, Engineered Cells and the CRISPR Revolution.- 2.  Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.- Part 2. CRISPR in Model Systems.- 3. From Reductionism to Holism: Toward a More Complete View of Development through Genome Engineering.- 4. Genome Engineering in Mice.- 5. Genome Editing to Study Ca2+ Homeostasis in Zebrafish Cone Photoreceptors.- 6. From Prokaryotic Immune Systems to Plant Genome Editing Tools.- 7. Part 3. The Future of CRISPR.- 7. Using High-throughput Gene Editing to Identify Therapeutic Targets in the Noncoding Genome.- 8. CRISPR in the Retina: Evaluation of Future Potential.- 9. The Future of CRISPR Applications in the Lab, the Clinic and Society.

From the B&N Reads Blog

Customer Reviews